Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of ERAS Clinical Pathway Intotally Laparoscopic Total Gastrectomy: a Multicenter, Prospective Randomized Controlled Study

NCT06489288 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06489288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of ERAS Clinical Pathway Intotally Laparoscopic Total Gastrectomy: a Multicenter, Prospective Randomized Controlled Study
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2024
Completion date
December 1, 2025
Enrollment
2,656 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eras, gastric cancer, laparoscopic gastrectomy